Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery-Reference-Cited by-同舟云学术

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

Published:2009-10-02 Issue:3 Volume:25 Page:401-404
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Bordeianou Liliana,Kunitake Hiroko,Shellito Paul,Hodin Richard

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00384-009-0800-5.pdf

Reference11 articles.

1. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE (2005) Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 128(4):862–869

2. Mor IJ, Vogel JD, Moreira Ada L, Shen B, Hammel J, Remzi FH (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51(8):1202–1207 discussion 1207-1210

3. Selvasekar CR, Cima RR, Larson DW et al (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204(5):956–962 discussion 962-953

4. Galandiuk S (2007) Discussion. J Am Coll Surg 204:962

5. Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4:94

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery;Gastroenterology;2022-07

2. Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients;European Journal of Gastroenterology & Hepatology;2020-10-16

3. Conventional and Biological DMARDs in Systemic Rheumatic Diseases;Handbook of Systemic Autoimmune Diseases;2018

4. Perioperativer Umgang mit immunsuppressiver Therapie;Der Chirurg;2017-12-20

5. The Role of Temporary Fecal Diversion;Clinics in Colon and Rectal Surgery;2017-05-22